首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Transferable Multidrug Resistance Plasmid Carrying cfr Associated with tet(L) ant(4′)-Ia and dfrK Genes from a Clinical Methicillin-Resistant Staphylococcus aureus ST125 Strain
【2h】

Transferable Multidrug Resistance Plasmid Carrying cfr Associated with tet(L) ant(4′)-Ia and dfrK Genes from a Clinical Methicillin-Resistant Staphylococcus aureus ST125 Strain

机译:携带cfr的可转移多药耐药质粒与来自临床耐甲氧西林金黄色葡萄球菌ST125菌株的tet(L)ant(4)-Ia和dfrK基因相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A multidrug resistance (MDR) conjugative plasmid of ca. 50 kb (designated pERGB) was detected in a linezolid and methicillin-resistant Staphylococcus aureus strain with sequence type 125 (ST125-MRSA-IVc). This strain was detected in two patients with chronic obstructive pulmonary disease, previously treated with multiple antimicrobials, including linezolid. pERGB was transferable by conjugation and carried the resistance genes cfr (oxazolidinones, phenicols, lincosamides, pleuromutilins, and streptogramin A), ant(4′)-Ia (tobramycin), tet(L) (tetracycline), and dfrK (trimethoprim). A novel genetic structure, linking all of these resistance genes for the first time, was elucidated through sequencing of a 15,259-bp fragment from pERGB. Active surveillance to prevent the dissemination of such highly concerning MDR transferable elements is needed.
机译:ca.的多药抗性(MDR)结合质粒。在对利奈唑胺和耐甲氧西林的金黄色葡萄球菌菌株125型(ST125-MRSA-IVc)中检测到50 kb(指定为pERGB)。在两名慢性阻塞性肺疾病患者中检测到该菌株,该患者先前已使用多种抗菌药物(包括利奈唑胺)进行了治疗。 pERGB可通过结合转移并带有抗性基因cfr(恶唑烷酮,苯甲酚,林可酰胺,截短侧耳素和链霉菌素A),ant(4')-Ia(妥布霉素),tet(L)(四环素)和dfrK(甲氧苄啶)。通过对来自pERGB的15259 bp片段进行测序,阐明了首次将所有这些抗性基因联系起来的新型遗传结构。需要积极监测,以防止这种高度关注的耐多药可转移成分的传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号